An Other News To Note news brief in the May 11, 2005, issue of BioWorld Today should have said that Benitec Ltd. is on track to begin Phase I trials of its RNA interference-based therapeutic for hepatitis C in the second half of 2006.

Editor's Note: The correction has been made in BioWorld Online.